TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells von Bartucci, M, Dattilo, R, Moriconi, C, Pagliuca, A, Mottolese, M, Federici, G, Benedetto, A Di, Todaro, M, Stassi, G, Sperati, F, Amabile, M I, Pilozzi, E, Patrizii, M, Biffoni, M, Maugeri-Saccà, M, Piccolo, S, De Maria, R

Volltext

miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer von Sacconi, A, Biagioni, F, Canu, V, Mori, F, Di Benedetto, A, Lorenzon, L, Ercolani, C, Di Agostino, S, Cambria, A M, Germoni, S, Grasso, G, Blandino, R, Panebianco, V, Ziparo, V, Federici, O, Muti, P, Strano, S, Carboni, F, Mottolese, M, Diodoro, M, Pescarmona, E, Garofalo, A, Blandino, G

Volltext

ATM kinase activity modulates ITCH E3-ubiquitin ligase activity von Santini, S, Stagni, V, Giambruno, R, Fianco, G, Di Benedetto, A, Mottolese, M, Pellegrini, M, Barilà, D

Volltext

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial von Garufi, C, Torsello, A, Tumolo, S, Ettorre, G M, Zeuli, M, Campanella, C, Vennarecci, G, Mottolese, M, Sperduti, I, Cognetti, F

Volltext

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine von Metro, G., Foglietta, J., Russillo, M., Stocchi, L., Vidiri, A., Giannarelli, D., Crinò, L., Papaldo, P., Mottolese, M., Cognetti, F., Fabi, A., Gori, S.

Volltext

Biobanking in a Constantly Developing Medical World von Lupu, Mihaela, Tataranu, Ligia Gabriela, Tache, Daniela Elise, Purcaru, Stefana Oana, Ciurea, Marius Eugen, Artene, Stefan-Alexandru, Dricu, A.

Volltext

Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer von Paris, O, Ferraro, L, Grober, O M V, Ravo, M, De Filippo, M R, Giurato, G, Nassa, G, Tarallo, R, Cantarella, C, Rizzo, F, Di Benedetto, A, Mottolese, M, Benes, V, Ambrosino, C, Nola, E, Weisz, A

Volltext

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer von Sette, G, Salvati, V, Mottolese, M, Visca, P, Gallo, E, Fecchi, K, Pilozzi, E, Duranti, E, Policicchio, E, Tartaglia, M, Milella, M, De Maria, R, Eramo, A

Volltext

Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer von Lattanzio, R, Ghasemi, R, Brancati, F, Sorda, R L, Tinari, N, Perracchio, L, Iacobelli, S, Mottolese, M, Natali, P G, Piantelli, M

Volltext

Effects of PARP-1 Deficiency on Th1 and Th2 Cell Differentiation von Pioli, C., Rosado, M. M., Bennici, E., Novelli, F., Laudisi, F., Sambucci, M.

Volltext

hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells von Trono, P, Di Modugno, F, Circo, R, Spada, S, Di Benedetto, A, Melchionna, R, Palermo, B, Matteoni, S, Soddu, S, Mottolese, M, De Maria, R, Nisticò, P

Volltext

High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity von Pierantoni, G M, Rinaldo, C, Esposito, F, Mottolese, M, Soddu, S, Fusco, A

Volltext

2196 Polymorphisms and miRNAs targeting CLOCK gene affect gender-related survival in metastatic colorectal cancer (mCRC) patients (pts) von Torsello, A, Ruzzo, A, Sperduti, I, Melucci, E, Giacomini, E, Mottolese, M, Fiorino, R, Zeuli, M, Pescarmona, E, Magnani, M, Cognetti, F, Garufi, C

Volltext

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort von Barba, M., Sperati, F., Stranges, S., Carlomagno, C., Nasti, G., Iaffaioli, V., Caolo, G., Mottolese, M., Botti, G., Terrenato, I., Vici, P., Serpico, D., Giordano, A., D’Aiuto, G., Crispo, A., Montella, M., Capurso, G., Delle Fave, G., Fuhrman, B., Botti, C., De Placido, S.

Volltext

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cance... von Vici, P., Brandi, M., Giotta, F., Foggi, P., Schittulli, F., Di Lauro, L., Gebbia, N., Massidda, B., Filippelli, G., Giannarelli, D., Di Benedetto, A., Mottolese, M., Colucci, G., Lopez, M.

Volltext

680 Role of ATM Kinase in HER2-triggered Tumor Progression von Stagni, V, Oropallo, V, Falcioni, R, Di Benedetto, A, Mottolese, M, Barila, D

Volltext

493: ATM kinase sustains HER2 tumorigenicity in breast cancer von Stagni, V, Oropallo, V, Mottolese, M, Di Benedetto, A, Manni, I, Piaggio, G, Falcioni, R, Di Carlo, S, Cencioni, M.T, Barilà, D

Volltext

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2... von Papaldo, P., Fabi, A., Ferretti, G., Mottolese, M., Cianciulli, A.M., Di Cocco, B., Pino, M.S., Carlini, P., Di Cosimo, S., Sacchi, I., Sperduti, I., Nardoni, C., Cognetti, F.

Volltext

P011 A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node of breast cancer von Buglioni, S, Terrenato, I, Casini, B, D'Alicandro, V, Di Filippo, F, Mottolese, M, Pescarmona, E

Volltext

Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer von Ferrandina, G., Ranelletti, F.O., Lauriola, L., Fanfani, F., Legge, F., Mottolese, M., Nicotra, M.R., Natali, P.G., Zakut, V.H., Scambia, G.

Volltext